[
    [
        {
            "time": "",
            "original_text": "泰格医药：公司在临床阶段为客户提供临床研发技术及咨询服务根据药物种类不同，临床阶段不同合同周期不尽相同",
            "features": {
                "keywords": [
                    "泰格医药",
                    "临床研发",
                    "咨询服务",
                    "合同周期"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "泰格医药：公司在临床阶段为客户提供临床研发技术及咨询服务根据药物种类不同，临床阶段不同合同周期不尽相同",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 4,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "CRO概念异动拉升 7只概念股获机构青睐",
            "features": {
                "keywords": [
                    "CRO概念",
                    "异动拉升",
                    "机构青睐"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "CRO概念异动拉升 7只概念股获机构青睐",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 8,
                "Duration": 5,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "医药生物行业周报：CDE发布《以临床价值为导向的抗肿瘤药物临床研发指导原则》",
            "features": {
                "keywords": [
                    "医药生物",
                    "CDE",
                    "临床价值",
                    "抗肿瘤药物",
                    "研发指导原则"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "医药生物行业周报：CDE发布《以临床价值为导向的抗肿瘤药物临床研发指导原则》",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 9,
                "Impact": 7,
                "Duration": 9,
                "Entity_Density": 4,
                "Market_Scope": 10,
                "Time_Proximity": 6,
                "Headline_Structure": 5,
                "Source_Recency": 7
            }
        }
    ]
]